BC Week In Review | Jan 14, 2013
Company News

Cytochroma, Opko deal

Cytochroma Inc. , Markham, Ontario   Opko Health Inc. (NYSE:OPK), Miami, Fla.   Business: Endocrine/Metabolic   Opko Health will acquire Cytochroma for $100 million in stock, plus up to $190 million in milestones. Opko will gain...
BC Extra | Jan 10, 2013
Company News

Opko acquires Cytochroma

Opko Health Inc. (NYSE:OPK) will acquire Cytochroma Inc. (Markham, Ontario) for $100 million in stock, plus up to $190 million in milestones. Opko will gain Cytochroma's two lead programs: Replidea ( CTAP101 ), which is in...
Items per page:
1 - 2 of 2